Showing results (371-380 of 3,769) with videos related to
Sort By:
Pageof 377
Radiation Oncology (London, England)|February 8, 2012
Accelerated partial breast irradiation using once-daily fractionation: analysis of 312 cases with four years median follow-upArif Y Shaikh, Michael A LaCombe, Hongyan Du, et al.Radiation Oncology (London, England)|February 8, 2012
A national survey of the availability of intensity-modulated radiation therapy and stereotactic radiosurgery in CanadaEman Z AlDuhaiby, Stephen Breen, Jean-Pierre Bissonnette, et al.Radiation Oncology (London, England)|January 25, 2012
The impact of direct aperture optimization on plan quality and efficiency in complex head and neck IMRTMarcello Sabatino, Matthias Kretschmer, Klemens Zink, et al.Radiation Oncology (London, England)|February 1, 2012
Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boostMichael Pinkawa, Marc D Piroth, Richard Holy, et al.Radiation Oncology (London, England)|March 31, 2012
Robotic-based carbon ion therapy and patient positioning in 6 degrees of freedom: setup accuracy of two standard immobilization devices used in carbon ion therapy and IMRTAlexandra D Jensen, Marcus Winter, Sabine P Kuhn, et al.Radiation Oncology (London, England)|March 22, 2012
A technique for pediatric total skin electron irradiationQinan Bao, Brian A Hrycushko, Joseph P Dugas, et al.Radiation Oncology (London, England)|March 21, 2012
DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activityHak Jae Kim, Jin Ho Kim, Eui Kyu Chie, et al.Radiation Oncology (London, England)|March 24, 2012
Comparison of intensity modulated radiotherapy (IMRT) with intensity modulated particle therapy (IMPT) using fixed beams or an ion gantry for the treatment of patients with skull base meningiomasKatsura Kosaki, Swantje Ecker, Daniel Habermehl, et al.Radiation Oncology (London, England)|March 28, 2012
Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrenceRenaud Mazeron, Agathe Bajard, Xavier Montbarbon, et al.Radiation Oncology (London, England)|April 5, 2012
Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trialAlexandra D Jensen, Jürgen Krauss, Karin Potthoff, et al.Pageof 377